Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD)

被引:6
|
作者
Dynka, Damian [1 ]
Rodzen, Lukasz [1 ]
Rodzen, Mateusz [1 ]
Lojko, Dorota [2 ]
Kraszewski, Sebastian [3 ]
Ibrahim, Ali [4 ]
Hussey, Maria [5 ]
Deptula, Adam [6 ]
Grzywacz, Zaneta [6 ]
Ternianov, Alexandre [7 ]
Unwin, David [8 ]
机构
[1] Rodzen Bros Fdn, PL-64234 Wielen, Poland
[2] Poznan Univ Med Sci, Dept Psychiat, PL-60572 Poznan, Poland
[3] Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, PL-50370 Wroclaw, Poland
[4] Schoen Inpatient Childrens Eating Disorders Serv, 147 Chester Rd,Streetly, Sutton Coldfield B74 3NE, England
[5] Private Gen Med Practice Mar Hussey, Ojcowa Wola 5, PL-14420 Mlynary, Poland
[6] Opole Univ Technol, Fac Prod Engn & Logist, 76 Proszkowska St, PL-45758 Opole, Poland
[7] Parc Sanit Pere Virgili, Primary Care Ctr Vila Olimp, C Joan Miro 17, Barcelona 08005, Spain
[8] Edge Hill Univ, Fac Hlth Social Care & Med, Ormskirk L39 4QP, England
关键词
nonalcoholic fatty liver disease (NAFLD); metabolic (dysfunction)-associated fatty liver disease (MAFLD); liver; ketogenic diet; low carb; insulin resistance; weight loss; microbiome; self-monitoring; treatment; LOW-CARBOHYDRATE-DIET; GUT MICROBIOTA; INSULIN-RESISTANCE; WEIGHT-LOSS; STEATOHEPATITIS NASH; MEDITERRANEAN DIET; METABOLIC SYNDROME; HEPATIC STEATOSIS; APPETITE; RESTRICTION;
D O I
10.3390/jcm13164857
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of nonalcoholic fatty liver disease (NAFLD) is likely to be approaching 38% of the world's population. It is predicted to become worse and is the main cause of morbidity and mortality due to hepatic pathologies. It is particularly worrying that NAFLD is increasingly diagnosed in children and is closely related, among other conditions, to insulin resistance and metabolic syndrome. Against this background is the concern that the awareness of patients with NAFLD is low; in one study, almost 96% of adult patients with NAFLD in the USA were not aware of their disease. Thus, studies on the therapeutic tools used to treat NAFLD are extremely important. One promising treatment is a well-formulated ketogenic diet (KD). The aim of this paper is to present a review of the available publications and the current state of knowledge of the effect of the KD on NAFLD. This paper includes characteristics of the key factors (from the point of view of NAFLD regression), on which ketogenic diet exerts its effects, i.e., reduction in insulin resistance and body weight, elimination of fructose and monosaccharides, limitation of the total carbohydrate intake, anti-inflammatory ketosis state, or modulation of gut microbiome and metabolome. In the context of the evidence for the effectiveness of the KD in the regression of NAFLD, this paper also suggests the important role of taking responsibility for one's own health through increasing self-monitoring and self-education.
引用
收藏
页数:27
相关论文
共 50 条
  • [41] A Lipidomic Readout of Disease Progression in Nonalcoholic Fatty Liver Disease (NAFLD)
    Pacana, Tommy
    Min, Hae K.
    Patel, Vaishali
    Katainen, Riikka
    Vihervaara, Terhi
    Mirshahi, Faridoddin
    Puri, Puneet
    Sanyal, Arun J.
    HEPATOLOGY, 2013, 58 : 531A - 531A
  • [42] Swimming training beneficial effects in a mice model of nonalcoholic fatty liver disease
    Schultz, Alini
    Mendonca, Leonardo S.
    Aguila, Marcia B.
    Mandarim-de-Lacerda, Carlos A.
    EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2012, 64 (04) : 273 - 282
  • [43] Beneficial effects of intermittent fasting on nonalcoholic fatty liver disease: a narrative review
    Deng, Qingxuan
    Lv, Ruyue
    Zou, Haoqi
    Zou, Tangbin
    EGYPTIAN LIVER JOURNAL, 2024, 14 (01)
  • [44] Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
    Kaswala, Dharmesh H.
    Lai, Michelle
    Afdhal, Nezam H.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) : 1356 - 1364
  • [45] Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD)
    Xin, Xin
    Chen, Cheng
    Hu, Yi-Yang
    Feng, Qin
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
  • [46] Nonalcoholic fatty liver disease (NAFLD): Approach in the adolescent patient
    Roberts E.A.
    Yap J.
    Current Treatment Options in Gastroenterology, 2006, 9 (5) : 423 - 431
  • [47] Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
    Ajay Duseja
    Naga Chalasani
    Hepatology International, 2013, 7 : 755 - 764
  • [48] THE NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) CONUNDRUM: HOW TO DEFINE IT?
    Mato, J. M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 5 - 5
  • [49] Nonalcoholic fatty liver disease (NAFLD): Diagnosis, pitfalls, and staging
    Koch, Lisa K.
    Yeh, Matthew M.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 37 : 83 - 90
  • [50] Burden of Nonalcoholic Fatty Liver Disease (NAFLD) in the United States
    Sanyal, Arun J.
    Estes, Chris
    Razavi, Homie
    HEPATOLOGY, 2016, 64 : 532A - 532A